Tianjin Baoheng Fudou Biotechnology Group Co., Ltd. (hereinafter referred to as Baoheng Group) was founded in 2003. It is an international enterprise group that spans many fields such as biotechnology, health care, hotel tourism, education and training, e-commerce, international trade, etc. Baoheng Group has innovated and developed natto health food, nutritious diet, smart home, frozen age the five main categories of skin care, daily chemicals and home cleansing have served nearly tens of millions of families.
In 2018, the Group spent RMB 3 billion on the purchase of 360 acres of land at No. 10 Yinhai Road, Jinghai Economic Development Zone, Tianjin to build a modern biological industrial park integrating R&D, production, administrative office, education and training, and logistics. The first phase of the project was completed and officially put into operation in August 2018, covering an area of 120 acres and a construction area of 57247.02 square meters.
The production base of Baoheng Health Industrial Park is a demonstration factory focusing on the world. It adopts international advanced design concepts and introduces the world's top fully automated production equipment. In terms of plant design, process technology, equipment and facility configuration, the goals of high-end, high-quality, high-level and high standard have been achieved, and the multiple requirements of ecology, environmental protection and energy saving have been achieved.
The group adopts an international standard management system, integrates laws and regulations of various countries, and strives to create a global quality management and food safety protection system for Baoheng Group. With its comprehensive strength, it has obtained domestic health food GMP certification and QS quality certification and has been approved as a national high-tech enterprise. Product quality assurance insurance is underwritten by PICC P&C Insurance. And in the domestic industry, it has taken the lead in passing the four international authoritative certifications of HACCP, BRC, FSMA and IFS.
In addition, Baoheng respects the religious culture of consumers of different religious beliefs, and has obtained the HALAL certification of Islam, and its core natto products have also passed the EU product standards., Obtained market access qualifications in the UnitedStates, Japan, Thailand, Myanmar, South Korea, Russia and other countries.
Baoheng Group has strong scientific and technological research and development capabilities. It has a number of independent intellectual property rights, the founder of the first generation of enzyme preparation technology, the first person in the domestic microbial field to engage in solid-state fermentation industrialization, Under the leadership of Professor Shu Wei, a new chapter in the core technology of total nutrition enzymatic hydrolysis was opened. Baoheng Group's natto health food is far ahead at home and abroad with the differentiated characteristics of "enzymes, bacteria, peptides" "high activity, original ecology, and complete nutrition".
On October 31, 2020, the conclusion analysis of the suitability clinical research of the Chinese Society of Geriatric Healthcare and Medical Research and Tianjin Baoheng Natto Product Expert Appraisal Meeting was held in Beijing. The Department of Cardiovascular Medicine of the First Clinical Medical Center of the PLA General Hospital has reached a clear conclusion through clinical observation and research: "The natto product produced by Tianjin Baoheng Biotechnology Co., Ltd. can effectively reduce the carotid plaque area, reduce the carotid plaque score, and reduce The level of low-density lipoprotein cholesterol, thereby reducing the possibility of atherosclerosis and thrombotic diseases, has a significant prevention and relief effect on thrombotic cardiovascular and cerebrovascular diseases." As a "phenomenal" product combining "prevention, intervention, and rehabilitation" in the treatment of cardiovascular and cerebrovascular diseases, natto monascus products have attracted the attention of well-known Chinese experts in cardiovascular and cerebrovascular diseases.